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Type I collagen inhibits differentiation and promotes a stem
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BACKGROUND: Human colorectal cancer is caused by mutations and is thought to be maintained by a population of cancer stem cells.
Further phenotypic changes occurring at the invasive edge suggest that colon cancer cells are also regulated by their
microenvironment. Type I collagen, a promoter of the malignant phenotype in pancreatic carcinoma cells, is highly expressed at the
invasive front of human colorectal cancer.
METHODS: This study investigates the role of type I collagen in specifying the colorectal cancer cell phenotype. The effect of type I
collagen on morphology, localisation of cell–cell adhesion proteins, differentiation and stem cell-like characteristics was examined in a
panel of human colorectal carcinoma cell lines.
RESULTS: Human colorectal carcinoma cells grown on type I collagen in serum-free medium show an epithelial–mesenchymal-like
transition (EMT-like), assuming a more flattened less cohesive morphology. Type I collagen downregulates E-cadherin and b-catenin
at cell–cell junctions. Furthermore, type I collagen inhibits differentiation, increases clonogenicity and promotes expression of stem
cell markers CD133 and Bmi1. Type I collagen effects were partially abrogated by a function-blocking antibody to a2 integrin.
CONCLUSION: Together, these results indicate that type I collagen promotes expression of a stem cell-like phenotype in human
colorectal cancer cells likely through a2b1 integrin.
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The human colorectal epithelium is maintained by a population of
multipotent adult stem cells that self-renew and execute a
multilineage differentiation programme yielding absorptive, mu-
cous and endocrine cells (Brittan and Wright, 2004). Human
colorectal carcinomas are heterogeneous and contain differen-
tiated cells (Ho et al, 1989), suggesting that cancer stem cells, with
a residual capability for multilineage differentiation, propagate
colorectal cancer. This concept is supported by the finding that
single-cell-derived populations of human colorectal cancer cells
have been shown to be both tumourigenic and capable of
multilineage differentiation (Kirkland, 1988; Vermeulen et al,
2008). Furthermore, several recent studies have isolated a sub-
population of cancer stem or tumour-initiating cells from human
colorectal cancers, which are functionally characterised by their
ability to seed new tumours (Dalerba et al, 2007; O’Brien et al,
2007; Ricci-Vitiani et al, 2007).
Epithelial–mesenchymal transition (EMT) has long been
implicated in cancer progression (Thiery and Sleeman, 2006),
although EMT-like would more accurately describe the changes
seen in most cancers where a full transcriptional reprogramming
to a mesenchymal phenotype is rarely observed (Klymkowsky and
Savagner, 2009). In human colon cancer, EMT-like changes are
observed in cells at the invasive edge, but these appear to be
reversible as disseminated cells recapitulate the morphology of the
primary tumour (Brabletz et al, 2005). Interestingly, EMT-like
phenotypic changes have recently been linked with stemness in
mammary epithelial cells (Mani et al, 2008) and the concept of
migratory cancer stem cells has been suggested (Brabletz et al,
2005) to describe human colon cancer progression.
The majority of human colon cancers carry mutations that lead
to the activation of Wnt signalling, a pathway that also has a
pivotal role in normal intestinal stem cell biology (Reya and
Clevers, 2005). Despite the underlying genetic background, cells
within individual tumours display differential Wnt signalling,
suggesting further regulation by the microenvironment. A local
loss of basement membrane at the invasive edge has been
suggested to expose cancer cells to a different microenvironment,
which promotes Wnt signalling (nuclear b-catenin expression),
EMT-like changes and loss of differentiation (Spaderna et al,
2006). Type I collagen is a known component of the microenvir-
onment at the host–tumour interface in human colorectal cancer
(Brabletz et al, 2004) and is more highly expressed in tumours
displaying infiltrative growth compared with those with expansive
growth (Oku et al, 2008).Type I collagen also reduces cdx-2
expression in human colorectal cancer cell lines in vitro (Brabletz
et al, 2004) and enhances tumourigenicity in human colorectal
cancer cells in xenografts (Del-Buono et al, 1991). Furthermore,
type I collagen promotes a malignant phenotype in pancreatic
cancer through a2b1 integrin (Grzesiak and Bouvet, 2006) and
forms part of a 17-gene signature associated with metastasis
(Ramaswamy et al, 2003).
Recently, the collagen receptor a2b1 integrin has been shown to
regulate stem cell fate in multipotent human colorectal cancer cells
(Kirkland and Ying, 2008), suggesting that collagen is involved in
the loss of differentiation observed at the invasive front. This study
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sinvestigates the effect of type I collagen on the phenotype of
human colorectal carcinoma cells.
MATERIALS AND METHODS
Cells
Three human colorectal cell lines were used in this study: HCA-7
Colony 29 (Marsh et al, 1993) termed Colony 29 in this study,
Caco-2 (ECACC) and a twice cloned population of HRA-19 cells
(Kirkland, 1988), which have been subjected to multiplex PCR
analysis (ECACC; Porton Down, Salisbury, UK) to confirm their
unique profile. Cell lines were grown in Dulbecco’s Eagle’s medium
(Invitrogen, Paisley, UK) supplemented with 10% foetal bovine
serum (FBS) in 7.5% CO2.
For experiments, cells were transferred to different serum-free
media, which are as follows:
IT: DMEM with 2mM glutamine and 1:100 of ITS-X supplement
(Invitrogen)
ITA: IT medium with 10mgml
 1 ascorbic acid
TS: DMEM with 2mM glutamine, 10mgml
 1 transferrin (Invitro-
gen) and 5ngml
 1 selenous acid (Sigma, Gillingham, UK).
Endocrine lineage commitment assay
Lineage commitment experiments were performed as previously
described (Kirkland and Henderson, 2001) or with minor
modifications.
Western blotting
Lysates were prepared with non-reducing SDS lysis buffer (New
England Biolabs, Hitchin, UK). Equal amounts of protein (RC-DC
assay; Bio-Rad, Hemel Hempstead, UK) were separated on 3–8%
Tris-acetate gels (Invitrogen) and blotted onto nitrocellulose. Blots
were stained with Ponceau S solution (Sigma) to check for equal
loading. Blots were blocked with 5% block solution (GE
Healthcare, Little Chalfont, UK), rinsed in wash buffer (10mM
Tris-HCl, 0.1 M NaCl, 0.1% Tween 20) and incubated overnight
with antibodies in the blot wash. Blots were washed and incubated
in horseradish peroxidase (HRP)-linked rabbit anti-mouse anti-
bodies (Dako, Ely, UK) in blot wash for 1h at room temperature,
washed and developed using ECL Plus (GE Healthcare).
Alkaline phosphatase assay
Subconfluent cells were removed from flasks with trypsin/EDTA
solution and added to 10% FBS in DMEM. Cells were washed twice
in DMEM and seeded in serum-free medium comprising
Dulbecco’s Eagle’s medium containing transferrin (10mgml
 1),
selenous acid (5ngml
 1) and 2mM glutamine (TS medium). Cells
were plated at 0.6 10
4 cells per well (Caco-2), 1.5 10
4 cells per
well (Colony 29) or a 1:5 split ratio (HRA-19). Cells were seeded
into collagen-coated 96-well plates (BioCoat; BD Biosciences,
Oxford, UK) or equivalent non-coated plates from BD Biosciences
(Biocoat plates are coated with 40–60mgml
 1 rat tail collagen:
manufacturer information). Occasional experiments were per-
formed using plates coated overnight at 41C with type I collagen
(Sigma) (10mgml
 1). After 72h at 371C, alkaline phosphatase
activity was measured using p-nitrophenyl phosphate (Millipore,
Watford, UK); the reaction product p-nitrophenol was measured at
405nm. Cell numbers were determined in replicate wells using
WST-1 reagent (Roche, Burgess Hill, UK) as described by the
manufacturer. Alkaline phosphatase absorbance values were
normalised using these WST-1 values.
Cell-based enzyme-linked immunosorbent assay
Quantitative analysis of differentiation and stem cell markers was
performed using a cell-based enzyme-linked immunosorbent assay
(ELISA) on whole cells in 96-well plates broadly as described
previously (Versteeg et al, 2000). Briefly, equal numbers of cells were
seeded onto either collagen-coated 96-well plates (Biocoat; BD
Biosciences) or control non-coated plates (BD Biosciences). Cells
were seeded as follows: HRA-19 (1:5 split ratio) (a single-cell
suspension could not be obtained for cell counting): Colony 29
(1.5 10
4 per well) and Caco-2 (0.66 10
4 per well) in the medium as
indicated. Cells were grown for the times indicated and then fixed in
ethanol for intestinal alkaline phosphatase expression or 2%
paraformaldehyde for CD133 and Bmi1 expression. Cells for Bmi1
measurements were further treated with ice-cold methanol for 20min.
Cells were washed three times with phosphate-buffered saline
(PBS) and endogenous peroxidase blocked with 0.3% H2O2 in PBS
for 30min at room temperature. Cells were then blocked in 10%
normal serum (species of secondary antibody), drained without
washing and incubated with primary antibody for 3h at room
temperature or overnight at 41C (CD133 (Abcam, Cambridge,
UK):Bmi1 (New England Biolabs):Intestinal Alkaline Phosphatase
(Abcam)). Wells were washed three times with PBS and then
incubated with HRP-conjugated secondary antibody for 1h at
room temperature. Finally, wells were washed three times in PBS
and once in distilled water and then HRP developed with
tetramethylbenzidine (Sigma), reaction stopped with H2SO4 and
absorbance read at 450nm (620nm reference). Background levels,
in the presence of isotype control antibodies at the same
concentration, were deducted from test values. Values were
normalised for cell number measured in replicate wells using
Cyquant cell proliferation assay (Invitrogen) as indicated by the
manufacturer.
To assess the role of a2b1 integrin in mediating the effects of
collagen, some experiments were performed in the presence of
MAb Ak7, a function-blocking antibody to a2 integrin (Gamble
et al, 1993).
Immunofluorescence
Immunofluorescence was performed in eight-chamber slides
(Nunc, VWR, Lutterworth, UK). Chambers were coated with type
I collagen (50mgml
 1 in 10mM acetic acid) (Sigma) overnight at
41C. Control wells were incubated with 10mM acetic acid.
Solutions were removed and wells dried for 2h before use. Cells
were grown in serum-free medium (TS)-DMEM with 2mM
glutamine, transferrin (10mgml
 1) and selenous acid (5ngml
 1)
for 72h in eight-chamber slides (Nunc).
Cells were fixed in 2% paraformaldehyde followed by methanol
to facilitate antibody access to intracellular antigens. Cells were
blocked with 10% normal serum (species of secondary antibody),
and drained and incubated overnight in primary antibody in 0.1%
BSA in PBS (CD133 (Abcam), Bmi1 (New England Biolabs), b-
catenin (New England Biolabs) and E-cadherin (BD Biosciences)).
Secondary antibodies were Alexa
488-conjugated Rabbit anti-Ms or
Goat anti-Rabbit Immunoglobulins (Invitrogen). Cells were
washed and counterstained with DAPI (Sigma) before mounting
in Permafluor (Thermo Scientific, Loughborough, UK).
Clonogenicity
Caco-2 cells were removed from flasks with Trypsin/EDTA
solution and then added to an equal amount of DMEM with 10%
FBS. Cells were washed twice with DMEM, and then suspended in
serum-free medium (TS). Cells were filtered through a 40-mm cell
strainer (BD Biosciences) to remove clumps and counted. A single-
cell suspension of Caco-2 cells was seeded into either BD Biocoat
6cm dishes or control uncoated dishes in serum-free medium
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weeks, and then fixed and stained with crystal violet. Colonies 410
cells were counted in the whole of each dish.
RESULTS
Type I collagen induces EMT-like changes in human
colorectal cancer cell lines
HRA-19, Colony 29 and Caco-2 cells were seeded onto tissue
culture plastic or type I collagen-coated dishes (BioCoat) in serum-
free medium. HRA-19 and Caco-2 cells showed a more flattened
less cohesive morphology on type I collagen (unpublished
observations), but Colony 29 cells displayed a dramatic scattering
of cells not previously described for a colon cancer cell line
(Figure 1A). Type I collagen also induced a downregulation of
E-cadherin at cell–cell junctions in Colony 29, Caco-2 cells and
HRA-19 cells (Figure 1B) although total E-cadherin protein was
not reduced (Figure 1D). Interestingly, there were substantial
differences in total E-cadherin between cell lines with a much
lower level of E-cadherin in Colony 29 cells, the cell line showing
the most marked morphological response to type I collagen
(Figure 1D and A).
b-Catenin showed strong membrane expression at cell–cell
contacts in Caco-2 cells on tissue culture plastic (Figure 1C),
whereas Caco-2 cells on type I collagen showed a downregulation
of cell–cell b-catenin and enhanced nuclear expression
(Figure 1C). Colony 29 cells showed both cell–cell and nuclear
b-catenin staining on plastic but on type I collagen; b-catenin was
predominantly localised in the nucleus (Figure 1C). HRA-19 cells
showed a strong cell–cell b-catenin expression on tissue culture
plastic, with a small reduction seen in spread cells on type I
collagen (Figure 1C), and nuclear b-catenin could only be
discerned in isolated cells (white arrow; Figure 1C).
As type I collagen is the preferred ligand for a2b1 integrin
(Kapyla et al, 2000), a2b1 integrin expression was also analysed.
Although a2b1 integrin expression was similar on plastic or
collagen, there were marked differences between cell lines
(Figure 1D). It was notable that the cell line that had the most
marked response to type I collagen, Colony 29, expressed much
higher levels of a2 integrin (Figure 1D).
Type I collagen inhibits lineage differentiation in human
colorectal cancer cells
Type I collagen was shown to markedly inhibit endocrine lineage
commitment in the multipotent human colorectal cancer line,
HRA-19 (Figure 2A).
Type I collagen was also shown to inhibit expression of the
enterocytic marker alkaline phosphatase (Matsumoto et al, 1990)
in Caco-2, Colony 29 and HRA-19 cells using an enzymatic method
for alkaline phosphatase assay (Figure 2B). Inhibition of enter-
ocytic differentiation markers was confirmed by measuring
intestinal alkaline phosphatase protein expression using a cell-
based ELISA. Cell-based ELISA has been shown to be a sensitive
assay for total (Versteeg et al, 2000) and cell surface (Hagi-Pavli
et al, 2004) protein expression in intact cell monolayers. Intestinal
alkaline phosphatase expression was shown to be markedly
reduced in all cell lines when grown on type I collagen compared
with plastic controls (Figure 2C).
Type I collagen increases the expression of stem cell-
associated markers CD133 and Bmi1
Recent studies have suggested that EMT is linked with the
expression of a stem cell phenotype. To examine this possibility,
cells undergoing EMT-like changes on type I collagen were
analysed for expression of putative stem cell markers CD133 and
Bmi1. An enhanced surface CD133 expression has been shown to
characterise a sub-population of human colorectal cancer cells
with tumour-initiating characteristics (O’Brien et al, 2007; Ricci-
Vitiani et al, 2007). Bmi1 has been shown to be a marker of adult
intestinal stem cells (Sangiorgi and Capecchi, 2008).
CD133 and Bmi1 expression was first confirmed by immuno-
cytochemistry. Colony 29 cells were shown to express CD133 in a
sub-population of cells (Figure 3A) and Bmi1 was expressed by the
majority of Colony 29 and HRA-19 cells (Figure 3B). Although
staining appeared stronger in cells on type I collagen, the pattern
of staining on plastic was indistinguishable from collagen cultures;
therefore, just images from collagen cultures were used to illustrate
-Catenin B
E-Cadherin 100
Col 29 Col 29
E-Cadherin
Caco-2 Caco-2
Plastic
C
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Figure 1 Type I collagen induces EMT-like changes in colorectal cancer
cell lines. (A) Phase contrast micrographs of Colony 29 cells grown for 48h
in serum-free medium (IT) on plastic tissue culture dishes (plastic) or dishes
coated with type I collagen (collagen I). Scale bar¼200mm.
(B) Immunofluorescent staining for E-cadherin expression in Colony 29,
Caco-2 and HRA-19 cells grown for 72h in serum-free medium (IT) on
tissue culture plastic (plastic) or collagen-coated plastic (collagen I). Cells
were imaged using fluorescence microscopy. Cells were counterstained
with DAPI (blue). Scale bars¼100mm. (C) Immunofluorescent staining for
b-catenin expression in Colony 29, Caco-2 and HRA-19 cells grown for
72h in serum-free medium (IT) on tissue culture plastic (plastic) or
collagen-coated plastic (collagen I). Cells were imaged using fluorescence
microscopy. White arrow in HRA-19 collagen panel shows a single cell with
nuclear b-catenin expression. Scale bars¼100mm. (D) Caco-2, Colony 29
and HRA-19 cells were seeded onto tissue culture plastic (Pl) or type I
collagen (Col)-coated plastic and incubated at 371C. Lysates were
prepared after 48h. Western blot for a2 integrin and E-cadherin was
performed on 10mg cell lysate.
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expression in HRA-19, Colony 29 and Caco-2 cells (unpublished
observations).
CD133 and Bmi1 expression was measured quantitatively
in a cell-based ELISA on tissue culture plastic or type I collagen.
The surface expression of CD133 was determined in cells follow-
ing fixation in paraformaldehyde without permeabilisation.
Type I collagen was shown to promote the cell surface expression
of CD133 in Colony 29 cells at 72h (Figure 4A). Bmi1 expres-
sion was also increased in HRA-19 and Colony 29 cells when
grown on type I collagen compared with tissue culture plastic
(Figure 4B).
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Figure 2 Collagen I inhibits lineage differentiation in human colorectal
cancer cells. (A) Endocrine lineage commitment in multipotent HRA-19
cells when grown on tissue culture plastic (TCP) and type I collagen-coated
plastic (collagen I). Equal numbers of cells were seeded at a 1:5 split ratio in
eight-chamber slides, grown for 72h in 10% FBS in DMEM and then
transferred to serum-free medium (ITA) for 72h. Monolayers were stained
for chromogranin using immunocytochemistry and total endocrine cells
counted in each chamber. Quadruplicate chambers were used for each
condition, results shown are combined values from three independent
experiments; mean±s.d. (n¼3); **Po0.001. (B) Alkaline phosphatase
activity in HRA-19, Caco-2 and Colony 29 cells grown in plastic(TCP) or
type I collagen (Col I)-coated 96-well plates for 72h in serum-free medium
(TS). Alkaline phosphatase absorbance values were normalised for cell
number using the WST-1 cell-proliferation reagent (Roche). The experi-
ment was performed in triplicate. Results shown are mean±s.d. (n¼3) for
three independent experiments; **Po0.005. (C) Intestinal alkaline
phosphatase expression in HRA-19, Caco-2 and Colony 29 cells grown
in plastic (TCP) or type I collagen-coated 96-well plates for 48h in serum-
free medium (TS). Intestinal alkaline phosphatase was measured using a
cell-based ELISA in triplicate with cell number normalised using Cyquant
assay (Invitrogen). Results shown are mean±s.d. (n¼3) for three
independent experiments; **Po0.005.
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Figure 3 Colon cancer cell lines express stem cell-associated markers
CD133 and Bmi1. (A) CD133 expression in Colony 29 grown in serum-
free medium (TS) for 48h. Cells were imaged using fluorescence
microscopy. CD133 (green), nuclear counterstain DAPI (blue). Con-
trol¼rabbit IgG control. Scale bar¼100mm. (B) Bmi1 expression in
Colony 29 cells and HRA-19 cells grown in serum-free medium (TS) for
72h. Cells were imaged using fluorescence microscopy. Bmi1 (green)
nuclear counterstain DAPI (blue). Control¼rabbit IgG control. Scale
bar¼50mm.
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Figure 4 Type I collagen increases the expression of stem cell markers
CD133 and Bmi1. (A) Cell surface expression of CD133 in Colony 29 cells
grown in serum-free medium (TS) in plastic or collagen-coated 96-well
plates for 72h. Measurements were made in triplicate using a cell-based
ELISA. Cells were fixed in 2% paraformaldehyde and not permeabilised to
detect surface expression. Results presented are mean±s.d. of three
independent experiments (n¼3); **Po0.005. (B) Bmi1 expression in
Colony 29 and HRA-19 cells grown in serum-free medium (TS) in plastic or
collagen-coated wells for 72h. Measurements were made in triplicate using
a cell-based ELISA. Results presented are mean±s.d. of three independent
experiments (n¼3); **Po0.005; *Po0.05.
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colorectal carcinoma cells
The clonogenicity of cells was compared on type I collagen-coated
and plastic surfaces using the Caco-2 cell line, which was the only
cell line from which a single-cell suspension could be generated.
Caco-2 cells showed an enhanced ability for clonal growth when
seeded on a type I collagen-coated surface in serum-free medium
(Figure 5A and B). Colonies generated on type I collagen also
appeared larger than those on plastic (Figure 5A).
Type I collagen effects are mediated through a2b1 integrin
The interaction of colon cancer cells with collagen through a2b1
integrin leads to the phosphorylation of focal adhesion kinase
(FAK) at Tyr
397 (Sawhney et al, 2006). FAK
397 was found to be
more highly phosphorylated in all cell lines on type I collagen
(Figure 6A), suggesting that integrin signalling was involved in the
cellular responses to collagen.
To directly assess the role of a2b1 integrin in EMT-like
phenotypic changes, Colony 29 cells were incubated with type I
collagen in the presence of an a2 integrin function-blocking
antibody, AK7, or a Ms IgG isotype control at the same
concentration. Type I collagen induced a cell scattering in control
cells, whereas Ak7 was shown to partially block the acquisition of
this distinctive migratory phenotype in Colony 29 cells (Figure 6B).
Enterocytic differentiation was also measured in cells on plastic
and on type I collagen in the presence of a2 integrin antibody, Ak7,
or Ms IgG control. Cells grown in control antibody showed the
previously described reduction in differentiation on type I
collagen, whereas the addition of Ak7 partially abrogated this
effect (Figure 6C). These results suggest that the type I collagen-
induced effects on the human colorectal cancer cell phenotype are
mediated, at least in part, by signalling through a2b1 integrin.
DISCUSSION
Transient changes in cancer cell phenotype are observed at the
invasive edge of human colorectal cancers, suggesting that the
microenvironment regulates tumour progression (Brabletz et al,
2001). Type I collagen is abundantly expressed at this invasive
front and preliminary studies have suggested that it is responsible
for the loss of differentiation and EMT-like changes seen in this
area (Brabletz et al, 2004). This study confirms and extends these
findings, showing that human colorectal carcinoma cell lines
undergo the initial steps of EMT when plated onto type I collagen.
These EMT-like changes include a spectrum of morphological
changes between cell lines ranging from a more flattened and less
cohesive morphology to the dramatic scattered morphology seen
in Colony 29. Further evidence of EMT-like changes on type I
collagen was provided by the downregulation of E-cadherin at
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Figure 5 Collagen I increases clonogenicity in Caco-2 cells. Caco-2 cells
(1 10
3) were seeded in serum-free medium (TS) into plastic or type I
collagen-coated (BioCoat) 6cm dishes. Cells were fed twice weekly for 5
weeks, then fixed and stained with crystal violet. Colonies with greater than
10 cells were counted. A representative experiment shows increased
colony formation on type I collagen-coated dishes (A) and the
corresponding colony counts for this experiment (B); *Po0.05. Similar
experiments were repeated four times.
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Figure 6 Collagen I effects are mediated through a2b1 integrin.
(A) Western blot showing total FAK and p-FAK expression in 10mg cell
lysate from Caco-2, Col 29 and HRA-19 cells after 2h on tissue culture
plastic (Pl) or type I collagen-coated plastic (Col). (B) Phase contrast
micrographs of Colony 29 cells grown in serum-free medium on tissue
culture plastic (plastic) or type I collagen-coated plastic dishes for 48h at
371C in the presence of either Ms IgG control (Ms) or anti-a2 integrin
(Ak7) at 300ngml
 1. Experiment was performed twice. Scale
bar¼100mm. (C) Cell-based ELISA for intestinal alkaline phosphatase
activity in Colony 29 cells grown on TCP or type I collagen-coated wells
(collagen) in the presence of varying concentrations of Ms IgG (Ms) or anti-
a2 integrin (Ak7). Values were normalised for cell number using WST-1
reagent. Triplicate wells were used for each condition. Results shown are
mean±s.d. **Po0.005; *Po0.05. Other experiments with individual
concentrations of antibody were performed at least three times with similar
results.
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cells (Grzesiak et al, 2005; Koenig et al, 2006). In pancreatic
carcinoma cells, some studies show an additional decrease in
E-cadherin protein on type I collagen (Koenig et al, 2006). In this
study, the downregulation of E-cadherin at cell–cell junctions
was not accompanied by a decrease in E-cadherin protein
expression in agreement with other studies on pancreatic
carcinoma cells (Shintani et al, 2006). However, constitutive
levels of E-cadherin were shown to be much lower in Colony 29
cells than in Caco-2 or HRA-19, raising the possibility that this
inherent characteristic rendered the cells more responsive to type I
collagen. Some evidence to support this notion comes from work
on the HCA-7 cell line, the parent line of Colony 29 cells, which
also shows a low level of E-cadherin protein expression (Chang
et al, 2006). In HCA-7 cells, E-cadherin is downregulated by
constitutive expression of COX-2 and RhoA, which are associated
with the disruption of adherens junctions in these cells (Chang
et al, 2006). COX-2-dependent pathways upregulate ZEB1 and
Snail, transcriptional suppressors of E-cadherin in lung cancer
cells (Dohadwala et al, 2006). ZEB1 represses differentiation and
cell–cell adhesion in human colorectal carcinoma cells (Aigner
et al, 2007). In addition, a stable COX-2 expression in breast
epithelial cells enhances EMT (Neil et al, 2008). Therefore, it seems
likely that the elevated levels of COX-2 in Colony 29 cells (Chinery
et al, 1999) are involved in enhancing the response of these cells to
type I collagen.
b-Catenin has dual functions in cell–cell adhesion and
transcription, with an imbalance between these two functions
leading to cancer formation (Harris and Peifer, 2005). Nuclear
b-catenin, an indicator of active Wnt signalling, acts as a
transcriptional activator in concert with TCF proteins and is both
important in normal stem cell renewal and the main oncoprotein
in human colorectal cancer (Peifer, 1997). The exposure of Colony
29 and Caco-2 cells to type I collagen resulted in a loss of b-catenin
at cell–cell contacts and an increase in nuclear b-catenin. Nuclear
b-catenin is observed in the invasive cells of human colorectal
cancer (Brabletz et al, 2001), suggesting that the exposure of cancer
cells to type I collagen at the invasive edge enhances nuclear b-
catenin expression. Nuclear b-catenin has been shown to impose
an undifferentiated progenitor phenotype on colorectal cancer
cells (van de Wetering et al, 2002); therefore, the differentiation
and expression of stem cell characteristics were compared between
cells growing on plastic and type I collagen.
Type I collagen has previously been shown to reduce cdx-2
expression in colon cancer cells (Brabletz et al, 2004). This study
confirms and extends this earlier study by showing that type I
collagen inhibits enterocytic differentiation in all cell lines tested.
The study was extended to compare cell fate decisions by
multipotent colorectal cancer cells (HRA-19) when grown on
tissue culture plastic and type I collagen. Endocrine lineage
commitment was inhibited by the growth of cells on type I
collagen, suggesting that type I collagen promotes self-renewal,
maintaining colorectal carcinoma cells in an undifferentiated
progenitor state.
This study shows that type I collagen induces EMT-like changes
and a loss of differentiation in human colorectal carcinoma cells.
Interestingly, recent studies have linked EMT with the acquisition
of stem cell properties in mammary epithelial cells (Mani et al,
2008). Therefore, stem cell marker expression was investigated to
determine whether the EMT-like changes observed on collagen
were similarly associated with a stem cell-like phenotype. Two
stem cell markers, CD133 and Bmi1, were chosen and Colony 29
cells investigated in greater detail as they displayed the greatest
EMT-like response to type I collagen. Cell surface CD133 has been
shown to be a stem cell marker in normal and neoplastic cells
(Mizrak et al, 2008), including human colorectal cancer stem cells
(O’Brien et al, 2007; Ricci-Vitiani et al, 2007).Cell surface
expression of CD133 was increased on Colony 29 cells grown on
type I collagen, suggesting that type I collagen maintains the stem
cell phenotype. Further evidence for this was sought using another
stem cell marker, Bmi1, which has a role in self-renewal in a
variety of stem cells and has recently been shown to be an
intestinal stem cell marker (Sangiorgi and Capecchi, 2008) . Colony
29 cells also showed increased Bmi1 expression when grown on
type I collagen, further supporting the idea that cells were
expressing a more stem cell-like phenotype. Increased Bmi1
expression was also observed in HRA-19 cells on type I collagen.
Bmi1 is involved in self-renewal in haematopoietic and neuronal
cells (Lessard and Sauvageau, 2003; Molofsky et al, 2003). In
addition, Bmi1 expression is dysregulated in preneoplastic color-
ectal epithelium and overexpression correlates with malignant
progression (Tateishi et al, 2006), supporting a role for Bmi1 in
human colorectal cancer progression. Previous studies have shown
that HRA-19 cells, which have a low inherent tumourigenicity,
acquired a 100% take rate in xenografts when embedded in type I
collagen gel (Del-Buono et al, 1991), suggesting a functional
significance to colon cancer cell–collagen interactions. To examine
whether an increased expression of stem cell markers was
accompanied by any functional attributes of stem cells, clonogeni-
city on type I collagen was determined. Clonogenicity is associated
with the stem cell phenotype and was enhanced in Caco-2 cells
when grown on type I collagen.
We have recently shown that a2b1 integrin regulates cell fate
decisions in the multipotent colorectal cancer cell line, HRA-19
(Kirkland and Ying, 2008).This study provides evidence that a2b1
integrin is involved in type I collagen-induced EMT-like changes
and loss of differentiation. However, Ak7, an a2 function-blocking
antibody, was only able to partially abrogate type I collagen-
induced effects on colon cancer cell phenotype, suggesting the
possible involvement of other collagen receptors. For example, it
has been shown recently that a2b1 integrin cooperates with
Discoidin domain receptor I, a tyrosine kinase collagen receptor,
to increase N-cadherin expression in pancreatic cancer cells
(Shintani et al, 2008).
In this study, the interaction between colon cancer cells and type
I collagen results in EMT-like changes, a loss of differentiation and
an increased expression of stem cell markers. These phenotypic
changes are all characteristics of cancer cells at the invasive edge of
human colorectal cancers. The link between EMT-like changes and
expression of a stem cell phenotype supports the concept of a
migrating cancer stem cell being involved in tumour progression
and dissemination (Brabletz et al, 2005). Overall, the results
indicate that type I collagen promotes the expression of a more
malignant, stem cell-like phenotype in human colorectal cancer
cells.
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